CVS CEO sees Longs Drug deal going through

SAN FRANCISCO (MarketWatch) - CVS Caremark Chief Executive Tom Ryan said Thursday he expects enough Longs Drug Stores shareholders will accept CVS' $2.9 billion bid despite some shareholder pressure to increase the deal price. 2 months ago